Ran Nussbaum Insider Trading $KITE Kite Pharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ran Nussbaum.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is Director in ARQULE INC ($ARQL) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Kite Pharma, Inc. ($KITE) and Director in Keros Therapeutics, Inc. ($KROS) and Director in UroGen Pharma Ltd. ($URGN) and Director in Prevail Therapeutics Inc. ($PRVL).

Ran Nussbaum in Kite Pharma, Inc.

Trading Symbol: KITE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Ran Nussbaum in Kite Pharma, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseD91.218,810803,5600
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseD50.877,000356,0900
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseD59.2310,000592,3000
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseD1.3550,00067,5000
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorSellD0.002,632002.6 K to 0 (-100.00 %)
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorSellD0.001,029001 K to 0 (-100.00 %)
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorSellD0.002,651002.7 K to 0 (-100.00 %)
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorSellD0.003,520003.5 K to 0 (-100.00 %)
Oct 05 2017KITEKite Pharma, Inc.Nussbaum RanDirectorSellD0.004,360004.4 K to 0 (-100.00 %)
Jun 22 2017KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseA91.218,810803,5608,810
Jun 22 2017KITEKite Pharma, Inc.Nussbaum RanDirectorGrantA0.002,41004,3602 K to 4.4 K (+123.59 %)
May 11 2017KITEKite Pharma, Inc.Nussbaum RanDirectorBuyP68.942,632181,4502,6320 to 2.6 K
May 11 2017KITEKite Pharma, Inc.Nussbaum RanDirectorBuyP69.171,02971,1761,0290 to 1 K
May 11 2017KITEKite Pharma, Inc.Nussbaum RanDirectorBuyP69.172,651183,3702,6510 to 2.7 K
May 11 2017KITEKite Pharma, Inc.Nussbaum RanDirectorBuyP69.173,520243,4783,5200 to 3.5 K
Jun 03 2016KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseA50.877,000356,0907,000
Jun 03 2016KITEKite Pharma, Inc.Nussbaum RanDirectorGrantA0.001,95001,9500 to 2 K
Jun 17 2015KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseA59.2310,000592,30010,000
Jun 03 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS56.0824,0701,349,846024.1 K to 0 (-100.00 %)
Jun 03 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS55.27200,60411,087,38324,070224.7 K to 24.1 K (-89.29 %)
Jun 03 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS57.387,800447,564224,674232.5 K to 224.7 K (-3.36 %)
Jun 03 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS56.443,754211,876232,474236.2 K to 232.5 K (-1.59 %)
Jun 03 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS55.0569,2063,809,790236,228305.4 K to 236.2 K (-22.66 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS59.9125,5601,531,40443,60469.2 K to 43.6 K (-36.96 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS59.9123,3491,398,934112,714136.1 K to 112.7 K (-17.16 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS59.9166,9484,011,129149,116216.1 K to 149.1 K (-30.99 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS61.2450,0003,062,05070,000120 K to 70 K (-41.67 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS61.2413,937853,516136,063150 K to 136.1 K (-9.29 %)
Mar 31 2015KITEKite Pharma, Inc.Nussbaum RanDirectorSellS61.2413,936853,455216,064230 K to 216.1 K (-6.06 %)
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseC0.00313,53100
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseC0.00807,68100
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorOption ExerciseC0.001,072,24500
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorBuyC0.00314,7430314,7430 to 314.7 K
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorBuyC0.00810,8030810,8030 to 810.8 K
Jun 27 2014KITEKite Pharma, Inc.Nussbaum RanDirectorBuyC0.001,076,39001,076,3900 to 1.1 M

Page:   1